Mouse Model of Pressure Ulcers After Spinal Cord Injury
March 9th, 2019
Here, we describe a simple method to induce clinically relevant skin pressure ulcers (PUs) in a mouse model of spinal cord injury (SCI). This model can be used in pre-clinical studies to screen for different therapeutics for healing PUs in SCI patients.
Overview
This study presents a method to induce skin pressure ulcers in a mouse model of spinal cord injury. This model is valuable for pre-clinical studies aimed at evaluating therapeutic options for healing pressure ulcers in patients with spinal cord injuries.
Key Study Components
Area of Science
- Neuroscience
- Wound Healing
- Animal Models
Background
- Pressure ulcers are a common complication in patients with spinal cord injuries.
- Understanding the dynamics of ulcer development and healing is crucial for effective treatment.
- Existing models may impair animal movement, limiting their utility.
- This study introduces a reproducible method that maintains animal mobility.
Purpose of Study
- To investigate the impact of spinal cord injury on pressure ulcer dynamics.
- To provide a platform for testing therapeutic strategies.
- To enhance understanding of wound healing processes in SCI patients.
Methods Used
- Induction of pressure ulcers in a mouse model.
- Use of anesthesia to ensure animal welfare during the procedure.
- Shaving and depilating the skin to prepare the ulcer site.
- Monitoring ulcer development and healing over time.
Main Results
- The method successfully induced pressure ulcers without impairing movement.
- Ulcer development and healing dynamics were effectively monitored.
- Various therapeutic strategies can be tested using this model.
- The model is reproducible and suitable for pre-clinical studies.
Conclusions
- This study provides a reliable model for studying pressure ulcers in SCI.
- The method allows for the evaluation of potential treatments.
- Future research can build on this model to improve patient outcomes.
Frequently Asked Questions
Executive Industry Relevance
Pressure ulcers following spinal cord injury represent a significant translational challenge in preclinical research, with direct implications for therapeutic development and wound healing strategies. This reproducible mouse model enables controlled investigation of ulcer formation and healing dynamics in the context of SCI, supporting predictive confidence in early-stage intervention studies. The model's clinical relevance and quantitative outputs position it as a critical tool for de-risking candidate therapies and informing portfolio advancement decisions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables mechanistic interrogation of wound healing pathways post-SCI in a controlled in vivo system.
- Supports biological de-risking by distinguishing healing dynamics above and below the injury site.
- Facilitates functional target validation for candidate interventions aimed at pressure ulcer repair.
Screening & Assay Development
- Provides a standardized, reproducible platform for evaluating therapeutic efficacy in pressure ulcer healing.
- Generates quantitative readouts such as wound closure rates and histological markers (Ki67, CD31, alpha smooth muscle actin).
- Enables reliable comparison of compound effects on tissue regeneration and vascularization post-SCI.
Translational & Preclinical Research
- Aligns with disease-relevant endpoints for SCI-associated wound healing and tissue repair.
- Supports continuity from discovery through preclinical validation of wound healing therapeutics.
- Informs risk-adjusted advancement of candidates targeting pressure ulcer complications in SCI populations.
Pipeline & Workflow Integration
This model integrates into the discovery-to-preclinical continuum for wound healing and SCI research, enabling hypothesis testing, target validation, and translational assessment of candidate therapies.
- Discovery Biology: Supports hypothesis-driven studies of impaired healing mechanisms post-SCI.
- Screening: Delivers reproducible, quantitative wound healing metrics for compound evaluation.
- Analytics: Provides histological and immunostaining outputs for comparative analysis of healing dynamics.
- Translational Research: Bridges preclinical findings to clinical scenarios of pressure ulcer management in SCI patients.
- Enterprise Reuse: Offers a reusable, standardized platform for iterative therapeutic testing and mechanistic studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in wound healing targets and reduces mechanistic ambiguity in SCI contexts.
- Operational Value: Enhances reproducibility and standardization across preclinical wound healing studies.
- Strategic Value: Improves go/no-go decision-making for candidate therapies targeting SCI-related complications.
- Portfolio Impact: Enables risk-adjusted prioritization of wound healing interventions for further development.
Implementation Considerations
- Requires expertise in surgical induction of SCI and pressure ulcers in mice.
- Demands access to imaging, histology, and immunostaining infrastructure for quantitative analysis.
- Necessitates cross-team standardization of wound induction and assessment protocols.
- Adaptation to other animal models or wound types may require protocol optimization.
- Variability in wound development can be minimized by precise magnet placement and procedural consistency.
Biopharma FAQs
Chapters in this video
0:04
Title
0:35
T9-T10 Spinal Laminectomy
2:22
T9-T10 Complete Spinal Injury
3:11
Induction of Skin Pressure Ulcer after Complete SCI
4:22
Post-operative Animal Care, Euthanasia, and Tissue Collection for Histology
5:07
Results: Skin Wound Histology and Impact on Healing
6:15
Conclusion
